Chemours (CC) PT Lowered to $30 at Barclays
Tweet
Share
E-mailGet Alerts CC Hot Sheet
Price: $15.24 +2.97%
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Barclays analyst Duffy Fischer lowered the price target on Chemours (NYSE: CC) to $30.00 (from $46.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Monopar Therapeutics (MNPR) PT Raised to $133 at BTIG
- Tokyo Tatemono Co Ltd (8804:JP) PT Raised to JPY4,480 at Nomura/Instinet
- Macquarie Upgrades Hankook Tire Co Ltd (161390:KS) to Outperform
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
